“SP tmw if results come out ? My guess is we see

“SP tmw if results come out ? My guess is we see 35 for a second then we close at 15-17. Then the following day’s we creep up all the way to 75 maybe higher all depends.”

This is a highly unlikely scenario for a few reasons. First, don’t just focus on the SP but also on outstanding shares and market cap. Other COVID19 have made large SP movements but they also had far less OS and a lower market cap. CYDY already has a $2 billion market cap and 500 million plus outstanding shares.

Second, if efficacy results are released, its most likely results from only the M2M trial will be released. Efficacy data is not part of the safety look into the severe trial. The M2M only has 85 patients so I think a phase 3 will be required (NP has said multiple times that a phase 3 is a possibility). So the question is: how far will the SP run on good efficacy data if a larger trial is still required? I’m hoping for an EUA with a phase 4.
Boom!

IMO, I think a BP is behind the scenes analyzing the data and is preparing to step in once the full data is available. NP has mentioned that a BP, or multiple BPs, are interested in the data. I guess we’ll find out soon.